THE HEALTHCARE CONTINUUM Trademark

Trademark Overview

On Monday, April 24, 2017, a trademark application was filed for THE HEALTHCARE CONTINUUM with the United States Patent and Trademark Office. The USPTO has given the THE HEALTHCARE CONTINUUM trademark a serial number of 87422082. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, December 6, 2024. This trademark is owned by Lonza Ltd.. The THE HEALTHCARE CONTINUUM trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Custom manufacturing services for others in the pharmaceutical and consumer healthcare industries, namely, custom manufacture of fine chemicals, advanced intermediates, active pharmaceutical ingredients (APIs), biologics, and functional ingredients
the healthcare continuum

General Information

Serial Number87422082
Word MarkTHE HEALTHCARE CONTINUUM
Filing DateMonday, April 24, 2017
Status710 - CANCELLED - SECTION 8
Status DateFriday, December 6, 2024
Registration Number5476927
Registration DateTuesday, May 22, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 29, 2017

Trademark Statements

Goods and ServicesCustom manufacturing services for others in the pharmaceutical and consumer healthcare industries, namely, custom manufacture of fine chemicals, advanced intermediates, active pharmaceutical ingredients (APIs), biologics, and functional ingredients
NOT AVAILABLE"HEALTHCARE"

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, December 6, 2024
Primary Code040
First Use Anywhere DateFriday, March 31, 2017
First Use In Commerce DateFriday, March 31, 2017

Trademark Owner History

Party NameLonza Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressVisp 3930
CH
Party NameLonza Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressVisp 3930
CH
Party NameLonza Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVisp 3930
CH

Trademark Events

Event DateEvent Description
Thursday, April 27, 2017NEW APPLICATION ENTERED
Friday, April 28, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, June 5, 2017ASSIGNED TO EXAMINER
Monday, June 12, 2017PRIORITY ACTION WRITTEN
Monday, June 12, 2017NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, June 12, 2017PRIORITY ACTION E-MAILED
Tuesday, June 13, 2017NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 13, 2017EXAMINERS AMENDMENT E-MAILED
Tuesday, June 13, 2017EXAMINERS AMENDMENT -WRITTEN
Tuesday, June 13, 2017EXAMINER'S AMENDMENT ENTERED
Tuesday, June 13, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 14, 2017ASSIGNED TO LIE
Wednesday, August 9, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 29, 2017PUBLISHED FOR OPPOSITION
Tuesday, August 29, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 24, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 23, 2018TEAS STATEMENT OF USE RECEIVED
Friday, March 23, 2018USE AMENDMENT FILED
Wednesday, April 11, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 11, 2018STATEMENT OF USE PROCESSING COMPLETE
Tuesday, April 17, 2018NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 17, 2018EXAMINERS AMENDMENT E-MAILED
Tuesday, April 17, 2018SU-EXAMINER'S AMENDMENT WRITTEN
Tuesday, April 17, 2018EXAMINER'S AMENDMENT ENTERED
Wednesday, April 18, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, April 19, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 22, 2018REGISTERED-PRINCIPAL REGISTER
Friday, May 17, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, May 17, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 22, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, December 6, 2024CANCELLED SEC. 8 (6-YR)

Related Keywords

continuum healthcare custom ingredients pharmaceutical advanced functional intermediates active chemicals biologics apis